Cipla has informed that a meeting of the Board of Directors of the Company will be held on Tuesday, 10th May 2022 to consider and approve the audited standalone and consolidated financial results for the quarter and year ended 31st March 2022 and recommendation of dividend, if any. In compliance with the provision of the Company's Code of Conduct for Prevention of Insider Trading, the ‘Trading Window' for dealing in the securities of the Company has been closed from Friday, 1st April, 2022 up to Thursday, 12th May, 2022.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1665.25 |
| Dr. Reddys Lab | 1220.75 |
| Cipla | 1232.90 |
| Zydus Lifesciences | 928.85 |
| Lupin | 2311.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: